Harel Insurance Investments & Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Hold |
198
| – | – | ﹤0.01% | 407 |
|
|
2025
Q1 | $10K | Hold |
198
| – | – | ﹤0.01% | 436 |
|
|
2024
Q4 | $10K | Hold |
198
| – | – | ﹤0.01% | 424 |
|
|
2024
Q3 | $13K | Hold |
198
| – | – | ﹤0.01% | 438 |
|
|
2024
Q2 | $12K | Hold |
198
| – | – | ﹤0.01% | 470 |
|
|
2024
Q1 | $11K | Hold |
198
| – | – | ﹤0.01% | 475 |
|
|
2023
Q4 | $11K | Hold |
198
| – | – | ﹤0.01% | 530 |
|
|
2023
Q3 | $9K | Buy |
+198
| New | +$9K | ﹤0.01% | 599 |
|